SEC Form 4 · accession 0001600132-17-000136
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore T Wang
Director · 10% Owner
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.25 | Dec 12, 2017 | A | 25,000 | A | — | Dec 11, 2027 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option vests in three equal annual installments over a three-year period from the date of Dr. Wang's board appointment on November 27, 2017.